Company Profile for STERIS Corporation
More News related to STE
- Izard Nobel LLP Announces Class Action Lawsuit Against STEC, Inc.
- STERIS Corporation (STE) Posts Q2 EPS of $0.54, Beats by 10c; Gudea and Declares $2.00 Special Dividend
- STERIS Corporation Announces Fiscal 2010 Second Quarter Results
- Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
- Company Profile for STERIS Corporation
More News related to Press Releases
- Hydrogenics Resumes Trading Under NASDAQ Symbol "HYGS"
- Varian Medical (VAR) to Highlight its New Range of Detectors at Annual RSNA Meeting in Chicago
- Manulife (MFC) Confirms No Exposure to Dubai World
- Activision's (ATVI) Call of Duty Amasses $3 Billion in Global Sales
- Seiko Epson to Transfer Sales Function of Small and Medium-Sized TFT LCD Business to Sony (SNE)
STERIS is a leading provider of infection prevention and surgical products and services, focused primarily on the critical markets of healthcare, pharmaceutical and research. The Company has approximately 5,000 dedicated employees around the world working together to supply a broad array of solutions by offering a combination of equipment, consumables and services to healthcare, pharmaceutical, industrial and government Customers. The Company is listed on the New York Stock Exchange under the symbol STE. For more information, visit www.steris.com.
Company: STERIS Corporation
Headquarters Address: 5960 Heisley Road
Mentor, OH 44060
Main Telephone: 440-354-2600
Website: www.steris.com
Ticker/ISIN: STE(NYSE)/US8591521005
Type of Organization: Public
Industry: Medical Devices
Earnings Release Dates: 1st Quarter: July 30, 2009
2nd Quarter: November 3, 2009
Key Executives: CEO: Walter Rosebrough
CFO: Michael Tokich
Investor Relations
Contact: Julie Winter
Phone: 440-392-7245
Email: julie_winter@steris.com
Source: STERIS Corporation
Related Categories
Press ReleasesStocks Mentioned
-0.39Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
